Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1Phase 2/3 1

Status

Unknown 2Recruiting 2Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1NET 1Lymphoid 1Gynecologic 1Gastrointestinal 1Endocrine 1Breast 1

Conditions

Serotonin Syndrome 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroendocrine Tumors 1Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma 1Esophageal Squamous Cell Carcinoma 1Carcinoid Tumors, Intestinal 1Carcinoid Tumor 1Breast Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Random Allocation × Clear all
NCT05361668 2026-03-19

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

Crinetics Pharmaceuticals Inc.

Phase 2 Completed
36 enrolled 19 charts
EndocrineNET

Carcinoid Tumors, Intestinal, Carcinoid Tumor, Neuroendocrine Tumors, Serotonin Syndrome

NCT06860269 2026-02-10

GRAALL-2024

Assistance Publique - Hôpitaux de Paris

Phase 2/3 Recruiting
1,200 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06348719 2025-09-15

ROBOT-ECO-GYN

Rennes University Hospital

Phase NA Recruiting
1,680 enrolled
Gynecologic

Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma

NCT02812641 2019-03-11

Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC

National Taiwan University Hospital

Phase 2 Unknown
50 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02590315 2019-01-31

ProteusDonna

Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Phase 4 Unknown
92,000 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡